Cardiovasc Prev Pharmacother.  2024 Apr;6(2):48-56. 10.36011/cpp.2024.6.e8.

Expectations and concerns regarding medical advertisements via large commercial medical platform advertising companies: a legal perspective

• Kim R
• Park H
• Shinn J
• Kim HS

• KMID: 2554781
• DOI: http://doi.org/10.36011/cpp.2024.6.e8

Abstract

Advertising in the medical and legal fields, which are among Korea's leading professions, has increasingly utilized major advertising platforms such as LawTalk and UNNI—two of the most prominent and contentious platforms in their respective fields. While it is generally unproblematic for professionals like lawyers and doctors to promote public interest through advertising on these commercial platforms, the creation of a profit-driven structure has the potential to undermine their professional ecosystems. This article explores the issues associated with advertising in the medical field through large commercial platforms, drawing on notable examples from the legal and medical fields in Korea. Specifically, we analyze two of the most popular yet controversial platforms in these sectors, LawTalk and UNNI. In Korea, the format and method of advertising are legal as long as they do not involve referring or soliciting clients, thereby making platform advertising lawful when used solely for that purpose. Nevertheless, it is crucial to prevent medical advertising platforms from establishing market monopolies by skirting various profit regulations and laws. In response to these concerns, the Korean Bar Association has prohibited all advertisements by platform companies. The medical community should closely examine the rationale and process behind this decision. Given the significant social influence of large corporate platforms and the unique social responsibilities of the medical and legal professions, future platform advertising should be subject to distinct legal and institutional regulations that differ from those applied to general services.

Keyword

Advertisement; Ethics; Jurisprudence; Lawyers; Medical staff

Figure

• 

  Fig. 1. The emergence of large platforms and the future of professional advertising.

Reference

1. Gruebner O, van Haasteren A, Hug A, Elayan S, Sykora M, Albanese E, et al. Digital platform uses for help and support seeking of parents with children affected by disabilities: scoping review. J Med Internet Res. 2022; 24:e37972.

2. Kim HS, Yoon KH. Lessons from use of continuous glucose monitoring systems in digital healthcare. Endocrinol Metab (Seoul). 2020; 35:541–8.

3. Kim HS. Towards telemedicine adoption in Korea: 10 practical recommendations for physicians. J Korean Med Sci. 2021; 36:e103.

4. Kim HS, Cho JH, Yoon KH. New directions in chronic disease management. Endocrinol Metab (Seoul). 2015; 30:159–66.

5. Litchfield I, Shukla D, Greenfield S. Impact of COVID-19 on the digital divide: a rapid review. BMJ Open. 2021; 11:e053440.

6. Kim HS, Kwon IH, Cha WC. Future and development direction of digital healthcare. Healthc Inform Res. 2021; 27:95–101.

7. Choung HU. A study on the legitimacy of legal tech. Chung-Ang Law Rev. 2022; 24:7–36.

8. Fair Trade Commission of Korea. [Sanctions against advertising restrictions on business operators of the Korean Bar Association and the Seoul Bar Association] [Internet]. Fair Trade Commission of Korea;2023. [cited 2023 May 23]. Available from: http://www.ftc.go.kr/www/selectReportUserView.do?key=10&rpttype=1&report_data_no=9954.

9. Constitutional Court of Korea. Decision of May 26, 2022 (2021Hun-Ma619) [Internet]. Constitutional Court of Korea;2022. [cited 2023 May 23]. Available from: https://www.ccourt.go.kr/jsp/View.jsp?cbIdx=1195&bcIdx=1003126.

10. Seoul Central District Court. Decision of January 27, 2022 (2021Godan4253) [Internet]. Seoul Central District Court;2022. [cited 2023 May 23]. Available from: https://seoul.scourt.go.kr/common/wcd/wcd.jsp.

11. Seoul Central District Court. Decision of May 26, 2022 (2021Gojung1855) [Internet]. Seoul Central District Court;2022. [cited 2023 May 23]. Available from: https://seoul.scourt.go.kr/common/wcd/wcd.jsp.

12. Sharma A, Harrington RA, McClellan MB, Turakhia MP, Eapen ZJ, Steinhubl S, et al. Using digital health technology to better generate evidence and deliver evidence-based care. J Am Coll Cardiol. 2018; 71:2680–90.

13. Howarth A, Quesada J, Silva J, Judycki S, Mills PR. The impact of digital health interventions on health-related outcomes in the workplace: a systematic review. Digit Health. 2018; 4:2055207618770861.

14. Park JI, Lee HY, Kim H, Lee J, Shinn J, Kim HS. Lack of acceptance of digital healthcare in the medical market: addressing old problems raised by various clinical professionals and developing possible solutions. J Korean Med Sci. 2021; 36:e253.

15. Korean Law Information Center. [Violation of the Medical Law: the Supreme Court of Korea’s Decision of October 25, 2012 (2010Do6527)] [Internet]. Korean Law Information Center;2012. [cited 2023 May 23]. Available from: https://www.law.go.kr/LSW/precStmdInfoP.do?precSeq=168594.

16. Korea Law Translation Center. Medical Service Act. Act No. 18468 (September 24, 2021) [Internet]. Korea Legislation Research Institute;2012. [updated 2023 May 11; cited 2023 May 23]. Available from: https://elaw.klri.re.kr/eng_service/lawView.do?lang=ENG&hseq=60889.

17. Korea Law Translation Center. Attorney-at-Law Act. Act No. 17828 (January 5, 2021) [Internet]. Korea Legislation Research Institute;[updated 2022 Jul 20; cited 2023 May 23]. Available from: https://elaw.klri.re.kr/kor_service/lawView.do?hseq=56111&lang=ENG.

18. Kim YM. A study on the administrative law on the improvement of medical advertising regulations. J Leg Stud. 2020; 28:21–54.

19. Pines WL. Direct-to-consumer advertising. Ann Pharmacother. 2000; 34:1341–4.

20. Shiragami M. Problems with advertisements for health foods. Yakugaku Zasshi. 2018; 138:1523–30.

21. Zaborovskyy V, Buletsa S, Bysaga Y, Manzyuk V, Lenher Y. Professional activity of medical lawyer. Georgian Med News. 2020; (300):146–52.

22. Roemer MI. The need for professional doctors of public health. Public Health Rep. 1986; 101:21–9.

23. Kim HS. Apprehensions about excessive belief in digital therapeutics: points of concern excluding merits. J Korean Med Sci. 2020; 35:e373.

24. R Niakan Kalhori S, Bahaadinbeigy K, Deldar K, Gholamzadeh M, Hajesmaeel-Gohari S, Ayyoubzadeh SM. Digital health solutions to control the COVID-19 pandemic in countries with high disease prevalence: literature review. J Med Internet Res. 2021; 23:e19473.

25. Kim HS. Lessons from temporary telemedicine initiated owing to outbreak of COVID-19. Healthc Inform Res. 2020; 26:159–61.

26. Korea Law Translation Center. Infectious Diseases Control and Prevention Act. Act No. 19644 (Aug 16, 2023) [Internet]. Korea Legislation Research Institute;[updated 2023 Dec 18; cited 2024 Feb 26]. Available from: https://elaw.klri.re.kr/kor_service/lawView.do?hseq=63486&lang=ENG.

27. Shin HY. [Non-face-to-face platform that encouraged “drug shopping” billed KRW 300 million for acne medication alone according to Shin Hyun-Young, a member of the National Assembly of Korea] [Internet]. Naver Blog;2022. [cited 2023 May 23]. Available from: https://blog.naver.com/shydeborah/222893113315.

28. Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020; 25:278–80.

29. Lim C. Babitalk eyes overseas markets after success in domestic market with unique marketing [Internet]. Aju Press;2022. [cited 2023 May 23]. Available from: https://www.ajudaily.com/view/20220404144145693.

30. German Federal Ministry of Justice. [Drug Advertising Act] (Heilmittelwerbegesetz – HWG) [Internet]. German Federal Ministry of Justice;[cited 2023 May 23]. Available from: https://www.gesetze-im-internet.de/heilmwerbg/BJNR006049965.html.

31. Press Office of the Federal Court of Justice. [Decision of the Federal Court of Justice for advertising remote medical treatments. Judgment of December 9, 2021 - I ZR 146/20] [Internet]. German Federal Court of Justice;2021. [cited 2023 May 23]. Available from: https://juris.bundesgerichtshof.de/cgi-bin/rechtsprechung/document.py?Gericht=bgh&Art=pm&Datum=2021&nr=124750&pos=10&anz=234.

32. German Federal Ministry of Justice. Act Against Unfair Competition (Gesetz gegen den unlauteren Wettbewerb - UWG) [Internet]. German Federal Ministry of Justice;[cited 2023 May 23]. Available from: https://www.gesetze-im-internet.de/englisch_uwg/index.html.